Change Language

Select Language

India Intravenous Solution Market to Grow at 5.95% During 2022-2027, Impelled by Increasing Incidences of Gastrointestinal Diseases

Published on Apr 18, 2022

According to the latest report by IMARC Group, titled "India Intravenous Solution Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the India intravenous solution market is expected to grow at a CAGR of 5.95% during 2022-2027. Intravenous (IV) solution refers to supplemental fluids that are generally used in intravenous therapy for maintaining the electrolyte balance in the patient’s body. It is usually injected into a vein with the help of an IV catheter or syringe for treating dehydration by restoring fluid volume in the body. It is widely adopted by healthcare professionals since the IV solution is a safe and simple procedure with a low risk of complications and the fastest way to deliver fluid replacement and medications to patients. As a result, it is extensively used across healthcare settings for providing nutrients that are added in the form of concentrations as per the patient’s size, age and medical condition.  

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

India Intravenous Solution Market Trends:

The market in India is primarily driven by the increasing incidences of gastrointestinal diseases. In line with this, the growing prevalence of diarrhea and vomiting that causes dehydration among individuals, coupled with the sedentary lifestyles and unhealthy eating habits of the masses, especially working professionals, is providing an impetus to the demand for IV solutions. Additionally, the sudden outbreak of coronavirus disease (COVID-19) has provided a boost to the product demand across the country. Moreover, continuous improvements in the healthcare sector due to the rising investments by private and public agencies to upgrade the existing infrastructure are propelling the market growth. Furthermore, numerous initiatives undertaken by the government for strengthening primary care in rural India are creating a positive market outlook. Other factors, including a considerable rise in the geriatric population, the expanding healthcare expenditure, the escalating number of clinics and health centers, and extensive research and development (R&D) activities conducted by key players, are also positively influencing the market.

Market Summary:

  • On the basis of type, the market has been bifurcated into partial and total parenteral nutrition.
  • Based on the nutrients, the market has been classified into carbohydrates, salts and electrolytes, minerals, vitamins and amino acids.
  • On the basis of the region, the market has been divided into North India, West and Central India, South India, and East India.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.


About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

USA: +1-631-791-1145
Follow us on twitter : @imarcglobal


Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91-120-433-0800 )

Drop us an email at